PDB59 LIXISENATIDE, BASAL INSULIN AND PREMIXED INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY ORAL ANTIDIABETIC DRUGS: NETWORK META-ANALYSIS AND COST-EFFECTIVENESS ANALYSIS
May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.608
https://www.valueinhealthjournal.com/article/S1098-3015(19)30800-9/fulltext
Section Title :
Section Order :
10229
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30800-9&doi=10.1016/j.jval.2019.04.608